Sansure Biotech Inc. (SHA:688289)
China flag China · Delayed Price · Currency is CNY
18.34
+0.26 (1.44%)
At close: Mar 6, 2026

Sansure Biotech Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
10,53010,85813,00111,18712,74723,600
Market Cap Growth
-10.75%-16.48%16.22%-12.24%-45.99%-48.22%
Enterprise Value
7,7178,0458,9826,4087,41718,716
Last Close Price
18.3418.9122.1018.5520.0534.89
PE Ratio
53.9454.8047.1730.766.5810.52
Forward PE
26.688.198.198.198.1912.20
PS Ratio
6.396.598.9211.111.985.23
PB Ratio
1.461.501.771.511.703.70
P/TBV Ratio
1.801.861.881.621.723.73
P/FCF Ratio
----6.3715.69
P/OCF Ratio
--47.37256.934.9812.57
EV/Sales Ratio
4.684.886.166.361.154.15
EV/EBITDA Ratio
22.5023.4533.5380.303.277.28
EV/EBIT Ratio
38.1239.7470.58-3.387.41
EV/FCF Ratio
----3.7112.44
Debt / Equity Ratio
0.150.150.060.010.000.00
Debt / EBITDA Ratio
3.213.211.530.400.010.01
Debt / FCF Ratio
----0.010.01
Net Debt / Equity Ratio
-0.40-0.40-0.59-0.64-0.75-0.73
Net Debt / EBITDA Ratio
-8.46-8.46-16.08-59.44-2.48-1.81
Net Debt / FCF Ratio
--29.3713.64-2.82-3.10
Asset Turnover
--0.170.110.790.72
Inventory Turnover
--0.730.778.043.97
Quick Ratio
--7.055.984.488.29
Current Ratio
--7.676.474.798.99
Return on Equity (ROE)
2.72%2.72%3.06%4.66%27.88%40.31%
Return on Assets (ROA)
--0.93%-0.15%16.86%25.17%
Return on Invested Capital (ROIC)
4.69%5.50%3.86%-0.78%102.20%186.47%
Return on Capital Employed (ROCE)
--1.60%-0.30%28.90%39.30%
Earnings Yield
1.88%1.82%2.12%3.25%15.19%9.50%
FCF Yield
---1.13%-3.11%15.69%6.37%
Dividend Yield
2.93%-2.38%2.49%6.47%2.18%
Payout Ratio
--97.39%110.10%33.92%19.61%
Buyback Yield / Dilution
0.61%0.61%0.05%-0.26%0.59%-6.55%
Total Shareholder Return
3.58%0.61%2.42%2.23%7.07%-4.37%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.